Erasca, Inc. () Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

3.23 M

Shareholding (Mar 2025)

FII

8.19%

Held by 74 FIIs

DII

45.55%

Held by 44 DIIs

Promoter

30.47%

How big is Erasca, Inc.?

22-Jun-2025

As of Jun 18, Erasca, Inc. has a market capitalization of 386.69 million, categorizing it as a Micro Cap company, with net sales of 0.00 million and a net profit of -157.60 million over the latest four quarters. As of Dec'24, the company reported shareholder's funds of 423.50 million and total assets of 502.53 million.

What does Erasca, Inc. do?

22-Jun-2025

Erasca, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $31 million and a market cap of $386.69 million. Key metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -33.82%.

Is Erasca, Inc. technically bullish or bearish?

05-Nov-2025

As of October 31, 2025, Erasca, Inc. shows a bullish technical trend despite underperforming the S&P 500, with daily moving averages and weekly MACD indicating bullish momentum, while the weekly RSI suggests short-term weakness.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 440 Million ()

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.80

Return on Equity

-32.44%

Price to Book

1.18

Revenue and Profits:

Net Sales:

(Quarterly Results - Jun 2025)

Net Profit:

-34 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

123.08%

6 Months

120.76%

1 Year

3.91%

2 Years

91.02%

3 Years

-58.08%

4 Years

-77.44%

5 Years

0.0%

Erasca, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

Is Erasca, Inc. technically bullish or bearish?

As of 31 October 2025, the technical trend for Erasca, Inc. has changed from mildly bullish to bullish. The current technical stance is bullish, driven primarily by the daily moving averages indicating bullish momentum and the weekly MACD also reflecting a bullish trend. However, the weekly RSI is bearish, suggesting some short-term weakness. The Bollinger Bands are mildly bullish on both weekly and monthly time frames, while the KST shows a bullish weekly signal but is bearish monthly. Despite the bullish indicators, Erasca's performance has been significantly underwhelming compared to the S&P 500, with a year-to-date return of -7.97% versus the S&P 500's 16.30%, and a one-year return of -15.07% compared to 19.89% for the index....

Is Erasca, Inc. technically bullish or bearish?

As of 31 October 2025, the technical trend for Erasca, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and Bollinger Bands are also indicating a bullish stance. Daily moving averages confirm a bullish trend. However, the monthly MACD is only mildly bullish, and the KST shows a bearish signal on that timeframe. Dow Theory presents a mixed view with a mildly bearish weekly signal and a mildly bullish monthly signal. The stock has underperformed compared to the S&P 500 across multiple periods, with a year-to-date return of -5.18% versus the S&P 500's 16.30%. Overall, the current technical stance is bullish, but the strength is tempered by mixed signals in some indicators....

Is Erasca, Inc. technically bullish or bearish?

As of 31 October 2025, the technical trend for Erasca, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and both the weekly and monthly Bollinger Bands are bullish, indicating positive momentum. The daily moving averages also support a bullish stance. However, the monthly KST is bearish, and the Dow Theory shows a mildly bearish signal on the weekly timeframe, which suggests some caution. In terms of performance, Erasca has outperformed the S&P 500 over the past week and month, with returns of 1.68% and 9.5% respectively, while it lags behind on a year-to-date and one-year basis. Overall, the current technical stance is bullish, with moderate strength driven by the positive indicators, despite some mixed signals in the longer-term metrics....

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

-156.46%

EBIT to Interest (avg)

-160.96

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.75

Sales to Capital Employed (avg)

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

96.54%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.13

EV to EBIT

-1.00

EV to EBITDA

-1.02

EV to Capital Employed

1.54

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

-154.32%

ROE (Latest)

-33.82%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

Bearish

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Bearish

Dow Theory

Mildly Bullish

OBV

No Trend

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Majority shareholders

Strategic Entities

Domestic Funds

Held in 38 Schemes (15.78%)

Foreign Institutions

Held by 74 Foreign Institutions (8.19%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 46.36% vs -98.74% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-29.80",
          "val2": "-44.20",
          "chgp": "32.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-7.50",
          "val2": "-22.50",
          "chgp": "66.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-33.90",
          "val2": "-63.20",
          "chgp": "46.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -29.28% vs 48.52% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-148.60",
          "val2": "-137.80",
          "chgp": "-7.84%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-27.20",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-161.60",
          "val2": "-125.00",
          "chgp": "-29.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Jun'25

Jun'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-29.80

-44.20

32.58%

Interest

0.00

Exceptional Items

-7.50

-22.50

66.67%

Consolidate Net Profit

-33.90

-63.20

46.36%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Jun 2024

Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 46.36% vs -98.74% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-148.60

-137.80

-7.84%

Interest

0.00

Exceptional Items

-27.20

0.00

Consolidate Net Profit

-161.60

-125.00

-29.28%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -29.28% vs 48.52% in Dec 2023

All Annual Results

Company CV

About Erasca, Inc.

Erasca, Inc.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available

Erasca, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

How big is Erasca, Inc.?

Watch in Real-Time

What does Erasca, Inc. do?

Is Erasca, Inc. technically bullish or bearish?

MarketsMojo — Loved in India, Now Global

Dashboard

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Is Erasca, Inc. technically bullish or bearish?

Is Erasca, Inc. technically bullish or bearish?

Is Erasca, Inc. technically bullish or bearish?

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Mar 2025

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Annual Results Snapshot (Consolidated) - Dec'24

About Erasca, Inc.

Company Coordinates